Skip Navigation

European Heart Journal 2001 22(16):1515-1516; doi:10.1053/euhj.2000.2549
Copyright © 2001 by the European Society of Cardiology.
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Cockcroft, J.R.
Right arrow Articles by Wilkinson, I.B.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Cockcroft, J.R.
Right arrow Articles by Wilkinson, I.B.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Letters to the Editor

A reply

J.R. Cockcrofta and I.B. Wilkinsonb

a Dept. of Cardiology, Wales Heart Research Institute, Cardiff, Wales, UK
b Clinical Pharmacology Unit, Addenbrook’s Hospital, Hills Road, Cambridge, UK

References

  1. Cockcroft JR, Wilkinson IB. Cholesterol reduction, statins and the cytochrome P-450 system. Eur Heart J. 2000;21:1555–1556[Free Full Text]
  2. Yeo KR, Yeo WW, Wallis EJ, Ramsay LE. Enhanced cholesterol reduction by simvastatin in diltiazem-treated patients. Br J Clin Pharm. 1999;48:610–615[CrossRef][Web of Science][Medline]
  3. Borttorff M, Hansten P. Long-term safety of hepatic hydroxymethyl glutaryl coenzyme A reductase inhibitors. The role of metabolism-monograph for physicians. Arch Intern Med. 2000;160:2273–2280[Free Full Text]
  4. Dresser GK, Spence JD, Bailey DG. Pharmacokinetic-pharmacodynamic consequences and clinical relevance of cytochrome P450 3A4 inhibition. Clin Pharmacokinet. 2000;38:41–57[CrossRef][Web of Science][Medline]
  5. Martindale: The Extra Pharmacopoeia. : The Royal Pharmaceutical Society; 1998.
  6. Sirotnak FM, Wendel HG, Bornmann WGB. Co-administration of probenecid, an inhibitor of a cMOAT/MRP-like plasma membrane ATPase, greatly enhanced the efficacy of a new 10-deazaaminopterin against human solid tumours in vivo. Clin Cancer Res. 2000;9:3705–3712
  7. Wilkie ME, Beer JC, Evans SJ. A double-blind randomised, placebo-controlled study of nifedipine on early renal allograft function. Nephrol Dial Transplant. 1994;9:800–804[Abstract/Free Full Text]
  8. Harper SJ, Moorhouse J, Abrams K. The beneficial effects of oral nifedipine on cyclosporin-treated renal transplant patients–a randomised prospective study. Transpl Int. 1996;9:115–125[CrossRef][Web of Science][Medline]
  9. Hilbrands LB, Hoitsma AJ, van Hamersvelt HW, Wetzels JF, Huysmans FT, Koene RA. Acute effects of nifedipine in renal transplant recipients treated with cyclosporin or azathioprine. Am J Kidney Dis. 1994;24:838–845[Web of Science][Medline]

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?



This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Cockcroft, J.R.
Right arrow Articles by Wilkinson, I.B.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Cockcroft, J.R.
Right arrow Articles by Wilkinson, I.B.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?